Loading...
Current and future standards in treatment of myasthenia gravis
Myasthenia gravis (MG) is a prototypic antibody-mediated neurological autoimmune disorder. Herein we characterize modern treatment algorithms that are adapted to disease severity, and introduce the current principles of escalating strategies for MG treatment. In non-thymoma patients younger than abo...
Na minha lista:
| Udgivet i: | Neurotherapeutics |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer New York
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514693/ https://ncbi.nlm.nih.gov/pubmed/19019304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2008.08.011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|